Clinical Trials
Gilead Terminates Phase III Clinical Trial of Ambrisentan in...
Gilead Sciences, Inc.announced it is stopping ARTEMIS-IPF, the company's ongoing Phase III clinical trial of ambrisentan in patients with idiopathic pulmonary fibrosis (IPF), due to...
Clinical Trials
Genentech Phase II study shows Pertuzumab and Herceptin Plus...
Genentech, a member of the Roche Group announced results from the NEOSPHERE trial, a Phase II neoadjuvant study evaluating the effect of a novel combination...
Clinical Trials
Novartis study shows drug Afinitor plus hormonal therapy...
A new study shows that the addition of everolimus (Afinitor® tablets) to the hormonal therapy tamoxifen in patients with hormone-receptor positive/human epidermal growth factor receptor...
Clinical Trials
Phase III study showed Rituxan/MabThera decreased the risk of...
Roche announced positive data from a Phase III study of Rituxan/MabThera (rituximab) in patients with advanced follicular lymphoma who did not have symptoms of disease...
Clinical Trials
QR Pharma receives FDA clearance to conduct clinical trials...
 QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), announced today that the United States Food and Drug Administration (FDA)...
Clinical Trials
Bayer and Regeneron Report Positive Top-Line Results of Two...
Bayer HealthCare and Regeneron Pharmaceuticals, Inc. announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet...
Clinical Trials
Reata and Abbott Announce Positive Phase 2b Study Results...
Abbott Park, Illinois-Reata Pharmaceuticals and Abbott today announced data from a Phase 2b study which suggests that bardoxolone methyl, an investigational treatment for chronic kidney...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.